151 related articles for article (PubMed ID: 34250406)
1. Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants.
Mezina A; Philips N; Bogus Z; Erez N; Xiao R; Fan R; Olthoff KM; Reddy KR; Samadder NJ; Nielsen SM; Hatchell KE; Esplin ED; Rustgi AK; Katona BW; Hoteit MA; Nathanson KL; Wangensteen KJ
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250406
[TBL] [Abstract][Full Text] [Related]
2. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.
Giri VN; Hartman R; Pritzlaff M; Horton C; Keith SW
JCO Precis Oncol; 2022 May; 6(1):e2200234. PubMed ID: 35666082
[TBL] [Abstract][Full Text] [Related]
3. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine.
You YN; Borras E; Chang K; Price BA; Mork M; Chang GJ; Rodriguez-Bigas MA; Bednarski BK; Meric-Bernstam F; Vilar E
Dis Colon Rectum; 2019 Apr; 62(4):429-437. PubMed ID: 30730459
[TBL] [Abstract][Full Text] [Related]
4. Detection of germline variants in Brazilian breast cancer patients using multigene panel testing.
Guindalini RSC; Viana DV; Kitajima JPFW; Rocha VM; López RVM; Zheng Y; Freitas É; Monteiro FPM; Valim A; Schlesinger D; Kok F; Olopade OI; Folgueira MAAK
Sci Rep; 2022 Mar; 12(1):4190. PubMed ID: 35264596
[TBL] [Abstract][Full Text] [Related]
5. Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer.
Ryu JS; Lee HY; Cho EH; Yoon KA; Kim MK; Joo J; Lee ES; Kang HS; Lee S; Lee DO; Lim MC; Kong SY
Cancer Sci; 2020 Oct; 111(10):3912-3925. PubMed ID: 32761968
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic Features.
Nguyen CB; Knaus C; Li J; Accardo ML; Koeppe E; Vaishampayan UN; Alva AS; Else T
JCO Precis Oncol; 2023 Sep; 7():e2300168. PubMed ID: 38127826
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Landscape of Pathogenic or Likely Pathogenic Germline Variants and Their Association With Somatic Phenotype in Unselected Chinese Patients With Gynecologic Cancers.
Wen H; Xu Q; Sheng X; Li H; Wang X; Wu X
JAMA Netw Open; 2023 Jul; 6(7):e2326437. PubMed ID: 37523182
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of
Schwartz AN; Hyman SR; Stokes SM; Castillo D; Tung NM; Weitzel JN; Rana HQ; Garber JE
JCO Precis Oncol; 2021 Nov; 5():1677-1686. PubMed ID: 34994652
[TBL] [Abstract][Full Text] [Related]
9. Germline cancer susceptibility in individuals with melanoma.
Funchain P; Ni Y; Heald B; Bungo B; Arbesman M; Behera TR; McCormick S; Song JM; Kennedy LB; Nielsen SM; Esplin ED; Nizialek E; Ko J; Diaz-Montero CM; Gastman B; Stratigos AJ; Artomov M; Tsao H; Arbesman J
J Am Acad Dermatol; 2024 Mar; ():. PubMed ID: 38513832
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.
Cotrim DP; Ribeiro ARG; Paixão D; de Queiroz Soares DC; Jbili R; Pandolfi NC; Cezana C; de Cássia Mauro C; Mantoan H; Bovolim G; de Brot L; Torrezan GT; Carraro DM; Baiocchi G; da Cruz Formiga MN; da Costa AABA
BMC Cancer; 2019 Jan; 19(1):4. PubMed ID: 30606148
[TBL] [Abstract][Full Text] [Related]
11. Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.
Carlo MI; Ravichandran V; Srinavasan P; Bandlamudi C; Kemel Y; Ceyhan-Birsoy O; Mukherjee S; Mandelker D; Chaim J; Knezevic A; Rana S; Fnu Z; Breen K; Arnold AG; Khurram A; Tkachuk K; Cipolla CK; Regazzi A; Hakimi AA; Al-Ahmadie H; Dalbagni G; Cadoo KA; Walsh MF; Teo MY; Funt SA; Coleman JA; Bochner BH; Iyer G; Solit DB; Stadler ZK; Zhang L; Rosenberg JE; Taylor BS; Robson ME; Berger MF; Vijai J; Bajorin DF; Offit K
J Clin Oncol; 2020 Feb; 38(5):406-414. PubMed ID: 31794323
[TBL] [Abstract][Full Text] [Related]
12. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
Tokunaga H; Iida K; Hozawa A; Ogishima S; Watanabe Y; Shigeta S; Shimada M; Yamaguchi-Kabata Y; Tadaka S; Katsuoka F; Ito S; Kumada K; Hamanaka Y; Fuse N; Kinoshita K; Yamamoto M; Yaegashi N; Yasuda J
PLoS One; 2021; 16(1):e0236907. PubMed ID: 33428613
[TBL] [Abstract][Full Text] [Related]
13. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic germline variants in BRCA1 and TP53 increase lung cancer risk in Chinese.
Wei B; Zhao J; Li J; Feng J; Sun M; Wang Z; Shi C; Yang K; Qin Y; Zhang J; Ma J; Dong H
Cancer Med; 2023 Dec; 12(23):21219-21228. PubMed ID: 37930190
[TBL] [Abstract][Full Text] [Related]
16. Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO.
Hoffman TL; Kershberg H; Goff J; Holmquist KJ; Haque R; Alvarado M
Fam Cancer; 2023 Apr; 22(2):225-235. PubMed ID: 36261688
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes.
Mossanen M; Nassar AH; Stokes SM; Martinez-Chanza N; Kumar V; Nuzzo PV; Kwiatkowski DJ; Garber JE; Curran C; Freeman D; Preston M; Mouw KW; Kibel A; Choueiri TK; Sonpavde G; Rana HQ
Clin Genitourin Cancer; 2022 Dec; 20(6):568-574. PubMed ID: 36127252
[TBL] [Abstract][Full Text] [Related]
18. Identification and Management of
Pal T; Brzosowicz J; Valladares A; Wiesner GL; Laronga C
South Med J; 2017 Oct; 110(10):643-648. PubMed ID: 28973705
[TBL] [Abstract][Full Text] [Related]
19. Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing.
Dominguez-Valentin M; Nakken S; Tubeuf H; Vodak D; Ekstrøm PO; Nissen AM; Morak M; Holinski-Feder E; Holth A; Capella G; Davidson B; Evans DG; Martins A; Møller P; Hovig E
Sci Rep; 2019 Dec; 9(1):18555. PubMed ID: 31811167
[TBL] [Abstract][Full Text] [Related]
20. Ethnic disparities among men with prostate cancer undergoing germline testing.
Kwon DH; Borno HT; Cheng HH; Zhou AY; Small EJ
Urol Oncol; 2020 Mar; 38(3):80.e1-80.e7. PubMed ID: 31630993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
